Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
Clinical trial NCT01032395 · COMPLETED
Trial details
- NCT number
- NCT01032395
- Sponsor
- Chiltern Pesquisa Clinica Ltda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-10-01
- Enrollment
- 342
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.